Global Pre-filled Syringes Market 2017-2021
About Pre-filled Syringes
The pre-filled syringe was introduced in the market in around 1975 as a part of the injectable drug delivery devices. It gained popularity and became the preferred packaging and delivery device for injectable drugs after the successful introduction of heparin pre-filled syringe by Sanofi and Rhone-Poulenc Rorer into the European market in the early 1980s. Approximately three to four billion pre-filled syringes are being produced annually and are expected to increase by 8%-10% every year. There is a deep interest in the healthcare industry for pre-filled syringe because of its convenience and acceptance by patients, indicating the strong growth potential of the pre-filled syringes market.
Technavio’s analysts forecast the global pre-filled syringes market to grow at a CAGR of 10.07 % during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global pre-filled syringes market for 2017-2021. To calculate the market size, the report considers the sales/value of pre-filled syringes.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Pre-filled Syringes Market 2017-2021
Technavio recognizes the following companies as the key players in the global pre-filled syringes market: BD, Gerresheimer, SCHOTT, Baxter, and TERUMO.
Other Prominent Vendors in the market are: AptarGroup, Bespak, Medtronic Minimally Invasive Therapies (formerly known as Covidien), NIPRO, SHL Group, STERINOVA, UNILIFE, Vetter Pharma-Fertigung GmbH & Co., and West Pharmaceutical Services.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Shift from glass pre-filled syringes to plastic pre-filled syringes .The plastic pre-filled syringes are becoming more popular due to the introduction of advanced polymer materials such as polypropylene and crystal-clear polymer, which are biocompatible with the other components of the syringe. Currently, the majority of pre-filled syringes in the global market were made of glass. However, over time manufacturers are switching to plastic as their preferred material for pre-filled syringe due to the inherent drawbacks of glass pre-filled syringes such as susceptibility to breakage and interaction with drugs.”
According to the report, one of the major drivers for this market is Favorable regulations and guidelines. In developed countries such as the US and Canada, there are laws or guidelines for mandatory protection of healthcare workers from needlestick injuries. In this context, the pre-filled syringes become an attractive choice, as it is equipped with needle safety devices, which can help to prevent the needle stick injuries. Many pre-filled syringes in the market provide features like automatic needle shielding or retractable needle options for safety from needle stick injuries.
Further, the report states that one of the major factors hindering the growth of this market is Competition from alternative drug delivery systems. The pre-filled syringes market faces intense competition from many alternative drug delivery systems such as microneedles, wearable and connected delivery devices, and nanopatches. These drug delivery devices are non-invasive, which are easier to use, provide painless delivery, and ensure the controlled release of the drug. However, the delivery of medicine by using pre-filled syringes is not pain-free. Hence, these novel technologies are expected to occupy a significant market share of the global drug delivery market. Companies such as UNILIFE and BD have already introduced wearable injector devices in the market. These devices are used as an alternative to hand-held instruments such as pre-filled syringes, particularly when delivering a dosage over pre-programmed periods from minutes to hours. Wearable injectors can be used to give a customizable dosage of biologics, vaccines, and small molecules to the patients.
BD, Gerresheimer, SCHOTT, Baxter, and TERUMO. AptarGroup, Bespak, Medtronic Minimally Invasive Therapies (formerly known as Covidien), NIPRO, SHL Group, STERINOVA, UNILIFE, Vetter Pharma-Fertigung GmbH & Co., and West Pharmaceutical Services.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook